The Surprising Debate: GLP-1s for Weight Maintenance?
Can a medication designed for obesity be used to maintain a normal weight? Christie Woodard's story sparks this intriguing question. After a successful bariatric surgery and a remarkable weight loss journey, Christie found herself facing a common challenge: keeping the pounds off.
But here's where it gets personal: Christie, standing at 5'5", maintains a healthy weight of 125 pounds with the help of a low-dose GLP-1 drug. This choice has raised eyebrows, as many wonder why someone who appears fit would need such medication. Yet, Christie's past struggles with obesity, which began in her 30s, are not visible to the naked eye.
Her journey to fitness included running half-marathons, but her weight made it physically demanding. After surgery, she halved her weight and set ambitious goals. However, despite her efforts, the weight started creeping back, affecting her physical and mental well-being.
Enter Dr. Betsy Dovec, who prescribed a low dose of Zepbound, a GLP-1 drug, even though Christie's BMI didn't indicate obesity. Dr. Dovec explains that GLP-1s treat more than just weight; they address metabolic diseases like diabetes and high blood pressure, and some doctors even use them off-label for alcohol use disorder. She believes that for patients like Christie, a multi-pronged approach, including surgery, diet, exercise, and GLP-1s, might be necessary.
However, Dr. Jennifer Manne-Goehler, an obesity specialist, raises a valid concern. She worries that individuals without excess weight might use these drugs purely for cosmetic reasons, potentially leading to muscle loss and fat regain when the medication is stopped. This could result in yo-yo dieting, which is harmful to the body.
The controversy deepens when considering the risks for those with disordered eating, as these disorders are not typically screened for when prescribing GLP-1s. Christie, having faced judgment and shame, now advocates for a nuanced understanding. She compares GLP-1s to statins for cholesterol, questioning why they should be viewed differently.
Christie's advocacy paid off when her employer's health insurance plan included coverage for GLP-1s, a rare occurrence. She argues that the medication reduces the need for various obesity-related medical appointments and treatments, saving costs for her employer. Moreover, she believes that feeling in control of her weight boosts her confidence and performance in all aspects of life.
And this is the part most people miss: Christie's experience highlights the complex relationship between weight, health, and societal expectations. It invites us to question our assumptions about weight management and consider the individual's unique circumstances. Should GLP-1s be reserved only for those with obesity, or can they be a tool for maintaining a healthy weight?
What do you think? Are GLP-1s a valid option for weight maintenance, or is it a slippery slope towards cosmetic use and potential misuse? Share your thoughts below, and let's explore this intriguing debate further.
